4.7 Review

Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections

期刊

LANCET INFECTIOUS DISEASES
卷 12, 期 4, 页码 330-340

出版社

ELSEVIER SCI LTD
DOI: 10.1016/S1473-3099(11)70341-3

关键词

-

资金

  1. Walloon Region
  2. GlaxoSmithKline Biologicals, Belgium
  3. biomedical sciences career award from Burroughs Wellcome Fund
  4. Canadian Institutes of Health Research
  5. SickKids Foundation
  6. Child and Family Research Institute (BC, Canada)
  7. Women and Children's Health Research Institute (AL, Canada)
  8. Manitoba Institute of Child Health

向作者/读者索取更多资源

Chronic infections during pregnancy are highly prevalent in some parts of the world. Infections with helminths, Trypanosoma cruzi, Plasmodium spp, and HIV might affect the development of fetal immunity and susceptibility to postnatal infections independently of in-utero transmission of the pathogens. Fetal adaptive immune responses are common in neonates who have been exposed to maternal infection during pregnancy but not infected themselves. Such responses could affect the development of immunity to the homologous pathogens and their control during the first few years of life. Fetal innate and regulatory responses might also affect immunity to unrelated pathogens and responses to vaccines. Strategies to improve child health should integrate the possible clinical implications of in-utero exposure to chronic maternal infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine

Byron Brook, Frederick Schaltz-Buchholzer, Rym Ben-Othman, Tobias Kollmann, Nelly Amenyogbe

Summary: The BCG vaccine not only reduces the risk of tuberculosis but also has beneficial effects on reducing respiratory infectious diseases and clinical malaria. These effects are associated with increased neutrophils and modulated neutrophil function.

VACCINE (2022)

Article Immunology

An instrument to measure psychosocial determinants of health care professionals' vaccination behavior: Validation of the Pro-VC-Be questionnaire

Pierre Verger, Lisa Fressard, Anna Soveri, Nicolas Dauby, Angelo Fasce, Linda Karlsson, Stephan Lewandowsky, Philipp Schmid, Eve Dube, Arnaud Gagneur

Summary: This study developed and validated the Pro-VC-Be instrument to measure vaccine confidence and other psychosocial determinants of HCPs' vaccination behavior among diverse HCPs in different countries, and assessed its impact on HCPs' vaccination behavior.

EXPERT REVIEW OF VACCINES (2022)

Article Microbiology

Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays

V Dirix, N. Dauby, M. Hites, E. Watelet, A. Van Praet, A. Godefroid, E. Petit, M. Singh, C. Locht, F. Mascart, V Corbiere

Summary: Optimal detection of latent tuberculosis infection (LTBI) is crucial for achieving tuberculosis elimination. A user-friendly whole-blood interferon gamma release assay (IGRA) was developed to improve the detection of LTBI. Clinical evaluation showed a sensitivity of 93% for detecting LTBI among asymptomatic individuals. Individuals with responses to both antigens are likely at risk for reactivating the infection and should be prioritized for prophylactic treatment.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

Article Immunology

Mortality Risk Among Frail Neonates and Maternal BCG Vaccine Scar Status: Observational Study From Guinea-Bissau

Frederik Schaltz-Buchholzer, Peter Aaby, Isaquel Silva, Ivan Monteiro, Tobias R. Kollmann, Nelly Amenyogbe, Morten Bjerregaard-Andersen, Christine Stabell Benn

Summary: This study suggests that maternal BCG vaccine may be associated with reduced overall NICU mortality rate in newborns.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Biochemical Research Methods

Antimicrobial susceptibility testing determined by Alfred 60/AST (Alifax®) in a multi-sites lab: performance's evaluation and optimization of workflow

R. Cupaiolo, S. Cherkaoui, G. Serrano, N. Dauby, A. Georgala, S. Blumental, E. Maillart, M. Hites, M. Hallin, D. Martiny

Summary: This study confirmed that Alfred 60/AST provides reliable and timely AST results, especially for Enterobacterales and enterococci. AST results for positive blood cultures can be obtained on the same day.

JOURNAL OF MICROBIOLOGICAL METHODS (2022)

Article Otorhinolaryngology

Comprehensive management of paranasal sinus fungus balls: A Young-IFOS consensus statement

Alberto Maria Saibene, Fabiana Allevi, Christian Calvo-Henriquez, Nicolas Dauby, Daniele Dondossola, Remi Hervochon, Jerome R. Lechien, David Lobo-Duro, Luca Giovanni Locatello, Antonino Maniaci, Giuditta Mannelli, Miguel Mayo-Yanez, Juan Maza-Solano, Thomas Radulesco, Neil Tan, Camilla Tincati, Manuel Tucciarone, Luigi Angelo Vaira, Leigh Sowerby

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2023)

Article Immunology

Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study

Goran Bencina, Andre Bento-Abreu, Ugne Sabale, Eleana Tsoumani, Valerie Laigle, Nicolas Dauby, Olivier Ethgen, Stina Salomonsson

Summary: The study aimed to estimate the individual lifetime cost of vaccination in 23 European countries, assuming full compliance with national immunization programs. The results showed that the individual lifetime cost of vaccination ranged from 592-3,504 euros for healthy individuals (median: 1,663 euros; 13-20 diseases), to 744-9,081 euros for individuals with underlying conditions (median: 2,992 euros; 13-21 diseases), and 1,225-4,832 euros in the scenario analysis (median: 2,565 euros; 21-22 diseases). The study suggests that the maximum potential cost of vaccination is relatively low with full compliance.

EXPERT REVIEW OF VACCINES (2023)

Review Parasitology

A systems biology approach to better understand human tick-borne diseases

Wenna Lee, Amanda D. Barbosa, Peter J. Irwin, Andrew Currie, Tobias R. Kollmann, Miles Beaman, Amy H. Lee, Charlotte L. Oskam

Summary: Tick-borne diseases pose a growing global health concern, and the immunological responses and inter-individual variations after tick bite remain unclear. By integrating clinical metadata and biological host data using advanced computational tools, we can gain a better understanding of tick-associated illnesses. This review emphasizes the importance of integrative system biology approaches for comprehending the complex pathobiology of tick-borne diseases.

TRENDS IN PARASITOLOGY (2023)

Article Infectious Diseases

Do people living with HIV travel safely? Assessment of travel patterns and advice-seeking behaviour in a cohort of people living with HIV in Belgium

Charlotte Martin, Emmanuel Bottieau, Marc Delforge, Nicolas Dauby

Summary: This study aimed to investigate the self-reported travel patterns and advice-seeking behavior among people living with HIV (PLWH) followed up at the HIV Reference Centre (HRC) of Saint-Pierre Hospital, Brussels. The results showed that a substantial number of PLWH were involved in visiting friends and relatives (VFR) travel in low-resource countries, and 65% sought pre-travel advice before traveling: if not, it was because they did not know it was necessary.

HIV MEDICINE (2023)

Article Infectious Diseases

Influenza versus other respiratory viruses-assessing severity among hospitalised children, Belgium, 2011 to 2020

Natalie Fischer, Sarah Moreels, Nicolas Dauby, Marijke Reynders, Evelyn Petit, Michele Gerard, Patrick Lacor, Siel Daelemans, Benedicte Lissoir, Xavier Holemans, Koen Magerman, Door Jouck, Marc Bourgeois, Benedicte Delaere, Sophie Quoilin, Steven Van Gucht, Isabelle Thomas, Nathalie Bossuyt, Cyril Barbezange

Summary: This observational study aimed to describe the burden of influenza viruses vs other respiratory viruses in children hospitalized with severe acute respiratory infections (SARI) in Belgium. The study analyzed data from routine national sentinel SARI surveillance and tested respiratory specimens collected during winter seasons from 2011 to 2020 using multiplex real-time quantitative PCR (RT-qPCR). The results showed that children infected with non-influenza respiratory viruses had a higher risk of complications compared to children with influenza only.

EUROSURVEILLANCE (2023)

Article Immunology

Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population

Sophie Marbaix, Nicolas Dauby, Joaquin Mould-Quevedo

Summary: This study compared the cost-effectiveness of the adjuvanted quadrivalent influenza vaccine (aQIV) with the standard (SD-QIV) and high-dose (HD-QIV) vaccines in elderly Belgians. The results showed that vaccinating older adults with aQIV instead of SD-QIV would decrease hospitalizations and deaths. Additionally, aQIV was found to be cost-saving compared to HD-QIV in a subgroup of institutionalized elderly adults. Therefore, a cost-effective vaccine like aQIV can reduce influenza-related hospitalizations and premature deaths in older adults.

EXPERT REVIEW OF VACCINES (2023)

Review Infectious Diseases

The value of herpes zoster prevention in patients aging with HIV: A narrative review

Nicolas Dauby, Christian Motet, Agnes Libois, Charlotte Martin

Summary: This article reviews the incidence and impact of herpes zoster among people living with HIV and the potential impact of recombinant zoster vaccine for people aging with HIV. The study found that although antiretroviral therapy has reduced the risk of herpes zoster among HIV patients, they still face a higher risk compared to the general population. Herpes zoster is associated with complications such as sight-threatening conditions, disseminated diseases, and stroke. The recombinant zoster vaccine has shown high efficacy in preventing herpes zoster and its complications. However, high vaccine price, vaccine hesitancy, and limited awareness pose challenges for vaccine uptake among aging HIV patients.

HIV MEDICINE (2023)

Article Medicine, General & Internal

Bacillus Calmette-Guerin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

Laure F. Pittet, Cecilia L. Moore, Ellie McDonald, Simone Barry, Marc Bonten, John Campbell, Julio Croda, Margareth Dalcolmo, Andrew Davidson, Mark W. Douglas, Kaya Gardiner, Amanda Gwee, Bruno Jardim, Marcus V. G. Lacerda, Michaela Lucas, David J. Lynn, Laurens Manning, Roberto D. de Oliveira, Kirsten P. Perrett, Cristina Prat-Aymerich, Peter C. Richmond, Jorge L. Rocha, Jesus Rodriguez-Bano, Adilia Warris, Nicholas J. Woods, Nicole L. Messina, Nigel Curtis

Summary: This study aimed to investigate the impact of the bacille Calmette-Guerin (BCG) vaccine on cold sore recurrences. The results showed that BCG vaccination could delay the recurrence of cold sores, especially in males with frequent recurrences. However, BCG vaccination also increased the risk of a first episode of cold sore.

ECLINICALMEDICINE (2023)

Article Public, Environmental & Occupational Health

Prevalence of hospital-associated infections and its association with discharge destinations and hospital readmissions in Brussels, Belgium, from 2008 to 2020: A hospital-based, cross-sectional study

Romain Mahieu, Melody Yannart, Nicolas Dauby, Boudewijn Catry, Sam Newton

Summary: This study examined time trends of hospital-associated infections (HAIs) in the Brussels-Capital Region and evaluated their consequences for hospitals and long-term care facilities. The results showed changes in the prevalence of HAIs over time, with a decrease from 2012 to 2014 and an increase from 2019 to 2020. A significant proportion of patients with HAIs were discharged to LTCFs and experienced early readmission. Longer hospital stays were associated with higher odds of LTCF discharge but lower odds of early readmission.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Immunology

Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19

Nicole L. Messina, Susie Germano, Rebecca McElroy, Rajeev Rudraraju, Rhian Bonnici, Laure F. Pittet, Melanie R. Neeland, Suellen Nicholson, Kanta Subbarao, Nigel Curtis

Summary: BCG vaccination has immunomodulatory effects on SARS-CoV-2 and reduces the secretion of cytokines associated with severe COVID-19. In addition, BCG vaccination promotes specific T cell immune responses and activates eosinophils.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

暂无数据